Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 8 results for "bristol myers squibb"

Bristol-Myers to license two drugs to Biogen, Roche

Bristol-Myers Squibb Co said on Thursday it would license two of its drugs to Biogen Inc and Roche Holding AG for an upfront fee of $470 million. Bristol will license its experimental neurodegenerative disorder drug, BMS-986168, to Biogen as a treatment for ... Reuters, 1 month ago

263 images for bristol myers squibb

WKRB News, 3 months ago
WKRB News, 3 months ago
WKRB News, 3 months ago
Live Trading News, 3 months ago
World Pharma News, 3 months ago
Live Trading News, 4 months ago
American Banking News, 3 months ago
Cancer Therapy Advisor, 4 months ago
Dotemirates.com, 4 months ago
PharmaVOICE, 4 months ago

Bristol-Myers NASH drug reduces liver fat in midstage study

Bristol-Myers Squibb Co said its lead experimental drug for nonalcoholic steatohepatitis, or NASH, significantly reduced liver fat versus placebo, according to data from a mid-stage trial presented at a medical meeting on Saturday. NASH, a progressive fatty ...
 Reuters1 month ago UK cost agency turns down Bristol drug for head and neck cancer  Reuters1 month ago Bristol-Myers immunotherapy combination extends survival in melanoma  Reuters1 month ago
DNA

AstraZeneca immunotherapy wins first approval in bladder cancer

⇒ Bladder cancer marks first approval for AZ's durvalumab ⇒ Big market is in lung cancer, where data due mid-year ⇒‚Äč AstraZeneca sets durvalumab price at $15,000/month US regulators have approved AstraZeneca's key immunotherapy drug ...
 DNA3 weeks ago Chinese drug approval boosts AstraZeneca's lung cancer hopes  Sify2 months ago
First Post.com

As AstraZeneca chases rivals, immuno-oncology gets complicated| Reuters

By Ben Hirschler | LONDON LONDON Three years after Pfizer's failed bid for AstraZeneca, the British drugmaker aims to prove in the coming weeks that its cancer immunotherapy can deliver on bold sales forecasts made during that takeover battle.Central to ...
 First Post.com1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less